Hepatitis B, a widespread viral infection, targets the liver and can lead to chronic issues if not managed. While some clear ...

More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

A new affordable housing complex officially opened in Bed-Stuy, Brooklyn, offering safe and affordable homes for seniors in ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective treatments for decades. The brains of people who die with Alzheimer’s show a ...

America’s cancer research system, which has helped save millions of lives, is under threat in one of its most productive ...

It’s this grey area which Lawrence finds himself. He’s not a bad quarterback, but he isn’t a special one either. Much like ...

Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer, Ajay ...

And back in the black as well. In the same nine-month period last year, Live Ventures reported a net loss of about $6.8 million. Today, that red ink has turned into $21.7 million in black. That's ...